UBS O'Connor’s Periphas Capital Partnering Corporation Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $28.75 PCPC.WS Stock Holding History
Bought
Maintained
Sold
Other funds holding PCPC.WS
RCM
BFM
SRCM
SCM
FTCM
PAMP
AMH
UBS O'Connor's PCPC.WS Position: Q2 2022 in Review
UBS O'Connor sold out of Periphas Capital Partnering Corporation Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $28.75 (PCPC.WS) in Q2 2022, closing a stake of 52,301 shares — an estimated $36K sold.
UBS O'Connor first reported a position in PCPC.WS in Q1 2021 and held it in 5 quarters. The position peaked at $108K in Q2 2021. 29 funds tracked by Wall St. Rank hold PCPC.WS as of Q2 2022.
- UBS O'Connor reported no remaining Periphas Capital Partnering Corporation Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $28.75 position as of Q2 2022 after selling out during the quarter.
- UBS O'Connor sold 52,301 Periphas Capital Partnering Corporation Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $28.75 shares in Q2 2022, an estimated $36K.
- UBS O'Connor first reported a position in Periphas Capital Partnering Corporation Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $28.75 in Q1 2021 and held it in 5 quarters.
- UBS O'Connor's Periphas Capital Partnering Corporation Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $28.75 position peaked at $108K in Q2 2021.
- 29 funds tracked by Wall St. Rank held Periphas Capital Partnering Corporation Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $28.75 as of Q2 2022.
Based on UBS O'Connor's 13F filing for Q2 2022, filed 12 Aug 2022.